Vunakizumab
Based on 1 Customer Validation
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody and an Interleukin-17A (IL-17A) inhibitor. Vunakizumab binds to IL-17A to inhibit downstream cytokines and block inflammatory signaling. Vunakizumab can be used for the research of chronic plaque psoriasis and ankylosing spondylitis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 95.00%
- CAS No.: 1792181-33-9
- Masse moléculaire:146.38 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
IL-17A |
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Product Details
-
CAS No. 1792181-33-9
-
Accession Q16552
-
Synonyms Anti-Human IL17A Recombinant Antibody; SHR-1314
-
Masse moléculaire 146.38 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Pureté
95.00%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Livraison
Shipping with dry ice.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Vunakizumab
- 1792181-33-9
- Anti-Human IL17A Recombinant Antibody
- SHR-1314
- SHR1314
- SHR 1314
- SHR-1314
- Interleukin Related
- IL
- thyroid-associated ophthalmopathy
- CD34+ orbital fibroblasts
- chronic plaque psoriasis
- inflammatory signaling
- Interleukin-17A
- fibrosis
- adipogenesis
- human CD34+ orbital fibroblasts
- ankylosing spondylitis
- IL-17A
- Inhibitor
- inhibitor
- inhibit